– Life Image partners with Graticule to help biopharma realize the full potential of advanced data in real-world evidence programs.
– Partnership combines Life Image’s global medical evidence network specializing in imaging data with Graticule’s deep expertise applying advanced data to high-value use cases.
Life Image, the world’s largest medical evidence network for clinical and imaging data has announced a new partnership with Graticule to help life sciences companies accelerate drug development and realize the full potential of advanced data in Real World Evidence (RWE).
Through this partnership, Life Image is combining its vast interoperable network and new RWI database with Graticule’s unmatched health IT and life sciences expertise to help biopharma companies optimize data aggregation, which is critical for more efficiently bringing life-saving medications to market and understanding disease progression and comparative effectiveness. As a result of this collaboration, biotech companies will be able to access and scale diagnostic and outcomes data for RWE.
Life Image recently launched its Real World Imaging solution of ‘living’ data sets, which consists of tens of millions of images and hundreds of thousands of associated reports and studies categorized by more than 25 anatomical parts including head, lung, breast, chest and more. The growing Life Image network of more than 1,500 U.S. facilities, 150,000 providers and 58,000 global clinics is fueled by a digital platform that is powered by industry-leading interoperability standards.
Graticule was formed by veteran healthcare and data entrepreneurs to help solve the many barriers that have impaired the use of advanced real-world data from complex sources such as imaging, pathology, voice, IoT and unstructured reports. Graticule provides advisory services and technology solutions to answer high-value questions by defining pragmatic analytical strategies and then sourcing, cleansing, and linking data to achieve them.
Why It Matters
“Given the complexities of life sciences, the industry needs more dynamic data and access to therapeutic endpoints to help understand disease progression and comparative effectiveness,” said Matthew A. Michela, CEO and President, Life Image. “The availability of Real World Imaging™ as part of Life Image’s access to clinical touchpoints in its global network combined with the advisory talent and technology of Graticule can help reduce the time and cost of getting life-saving medicines to patients.”